bjs9101-sup-0001-FigureS1.docWord document54KFig S1 Funnel plots for all outcomes analysed: a 30-day or in-hospital all-cause mortality, b 2-year all-cause mortality, c 4-year or greater all-cause mortality, d aneurysm-related mortality, e aneurysm rupture, f reintervention, g stroke, h myocardial infarction and i renal failure (Word document)
bjs9101-sup-0002-FigureS2.docWord document68KFig S2 Sensitivity analysis: Forest plot comparing all-cause mortality at a,b 30 days or in hospital, c,d 2 years and e,f 4 years or more after endovascular aneurysm repair (EVAR) versus open repair in a,c,e randomized controlled trials (RCTs) and b,d,f non-randomized studies (Word document)
bjs9101-sup-0003-FigureS3.docWord document54KFig S3 Sensitivity analysis: Forest plot comparing a rupture, b reintervention, c renal failure and d myocardial infarction after endovascular aneurysm repair (EVAR) versus open repair in randomized controlled trials. A Mantel–Haenszel random-effects model was used for meta-analysis. Odds ratios are shown with 95 per cent confidence intervals (Word document)
bjs9101-sup-0004-TableS1.docWord document60KTable S1 Baseline characteristics of participants in each trial at primary and most recent publication (Word document)
bjs9101-sup-0005-TableS2.docWord document38KTable S2 Endograft devices used for endovascular aneurysm repair in each study (Word document)

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.